Although subsequent investigations have consistently shown that the DNAJB1-PRKACA transcript or the resultant fusion is 100% specific for FL-HCC [31], one multi-institutional study alone reported that 10–20% of FL-HCC specimens examined were negative for this fusion transcript [32]. This evidence concerns the gene DNAJB1 and hepatocellular carcinoma.